Your Iron Tests Look Normal, Yet You're Still Exhausted. Your Genes May Explain Why.

HFE is the master iron-sensing gene. It encodes a protein that sits on the surface of liver cells and measures your body’s iron load. When iron is high, HFE signals the release of hepcidin, a hormone that tells your gut to stop absorbing iron. When iron is low, HFE steps back and hepcidin drops, allowing iron absorption to ramp up.

The C282Y variant in HFE, carried by roughly 1 in 250 people of European descent, essentially breaks this sensor. People with two copies of C282Y can’t turn off iron absorption, leading to iron overload (hemochromatosis) and organ damage. The H63D variant, carried by 15-20% of European ancestry populations, is more subtle but still problematic. H63D reduces the sensitivity of iron sensing, meaning your body may not recognize when iron is low and trigger the absorption response you need. This is especially true if you’re also genetically predisposed to low Vitamin D or have MTHFR variants that impair methylation.

If you carry H63D, your body is a poor iron waster. You lose iron faster than the signaling system recognizes, and by the time hepcidin drops enough to increase absorption, you’re already deficient. This feels like chronic fatigue, brain fog, and hair loss that no amount of supplemental iron seems to fix.

TMPRSS6 encodes a protease that regulates hepcidin, the master hormone of iron absorption. When iron is low, TMPRSS6 helps suppress hepcidin, allowing iron to flood in. If TMPRSS6 is working well, even mild iron deficiency triggers a proportional increase in absorption, and you stay in balance. If TMPRSS6 has a variant, the response is blunted.

The rs855791 variant in TMPRSS6, carried by roughly 45% of the population, impairs this hepcidin-lowering mechanism. People with this variant have a genetic bias toward lower iron absorption and lower ferritin levels. Even when you eat iron or take supplements, your gut doesn’t absorb it as readily, and your body doesn’t store it as readily either. You’re genetically wired to be an iron loser.

If you carry the TMPRSS6 variant, you experience what feels like iron resistance. You take iron supplements and feel nothing. Your ferritin slowly creeps down. Over months or years, you develop anemia despite consistent effort. Your doctor might blame poor adherence or poor diet quality when the real problem is that your genes are programmed to let iron slip away.

Vitamin D and iron absorption are biologically inseparable. Vitamin D receptor (VDR) sits on intestinal epithelial cells and regulates the expression of genes that encode iron transporters. If VDR is not working properly, even if your Vitamin D levels look adequate, your intestinal cells can’t mount an iron-absorption response.

The FokI, BsmI, and TaqI variants in VDR, carried by 30-50% of people, reduce the efficiency of the Vitamin D receptor. People with these variants often have functional Vitamin D deficiency: their tissue Vitamin D levels are low despite supplementation, and their intestinal iron-absorption machinery never fully activates. This creates a hidden cascade: low VDR sensitivity leads to functional Vitamin D deficiency, which collapses iron absorption, which causes iron deficiency anemia despite adequate iron intake.

If you carry VDR variants, you experience a double bind. You might supplement iron dutifully but absorb only a fraction of it because your VDR is not driving the intestinal transporters that would normally pull it in. Meanwhile, your Vitamin D levels stay stubbornly low no matter how much you supplement. The two deficiencies feed each other, and standard supplementation doesn’t break the cycle.

MTHFR is the gatekeeper of the methylation cycle, which includes the conversion of folate and cobalamin (B12) into their active forms. These active forms are required for dozens of enzymatic reactions, including the production of hemoglobin and the regulation of hepcidin. If MTHFR is not working efficiently, you don’t just develop deficiency in folate and B12; you also impair iron metabolism.

The C677T variant in MTHFR, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 40-70%. People with C677T have a functional B12 and folate deficiency, which cascades into weak methylation and impairs the production and regulation of hepcidin. Your iron might be getting absorbed, but your body can’t regulate it properly, can’t build hemoglobin efficiently, and can’t maintain iron homeostasis.

If you carry MTHFR C677T, iron deficiency often comes packaged with neurological symptoms (brain fog, anxiety, poor concentration) and delayed recovery from exertion. You might have taken iron supplements for years, normalizing your ferritin, and still felt exhausted. The reason: your MTHFR variant was preventing your body from using the iron efficiently.

SLC30A8 encodes a zinc transporter in pancreatic beta cells. Zinc is essential for insulin synthesis and secretion, and insulin resistance silently undermines iron absorption by increasing hepcidin. But zinc deficiency also impairs intestinal metallothionein, a protein that both absorbs and releases iron in a coordinated fashion. Without adequate zinc, your intestinal iron transport becomes chaotic.

The R325W variant in SLC30A8 (rs13266634), where the W allele is present in roughly 30% of people, impairs zinc transport into pancreatic cells and reduces zinc bioavailability in the gut. People with this variant have reduced zinc absorption, which decreases intestinal iron transport efficiency and increases the risk of both zinc and iron deficiency simultaneously. This is especially problematic if you’re also carrying MTHFR or VDR variants, because zinc is a cofactor for multiple enzymes in those pathways.

If you carry the SLC30A8 W allele, you might notice that iron supplements alone don’t restore your energy, even at high doses. The reason: your zinc status is chronically low, and zinc is the actual limiting factor in your intestinal iron transport. Adding iron without restoring zinc creates an imbalance.

COMT metabolizes dopamine and norepinephrine, two neurotransmitters that regulate stomach acid production, intestinal motility, and the sympathetic nervous system. Stomach acid is essential for dissolving iron and making it absorbable in the upper intestine. If COMT is slow, dopamine and norepinephrine accumulate, shifting your nervous system toward parasympathetic dominance, and stomach acid production can drop.

The Val158Met variant in COMT, with the Met allele present in roughly 30-40% of people, creates slower dopamine clearance. People with the slow COMT variant (Met/Met) often have lower stomach acid production, which means less iron dissolves in the stomach and less iron gets absorbed in the duodenum, even if the iron-transport genes are working well. Paradoxically, slow COMT also reduces gastric motility, slowing food transit and giving more time for absorption, but the net effect is usually reduced absorption because of the acid deficit.

If you carry slow COMT variants, you might notice that iron supplements cause stomach upset (because they’re not dissolving well and sitting heavy) or that you absorb them poorly despite your best efforts. Stress and caffeine make it worse by flooding your system with dopamine that can’t clear. Your stomach becomes less acidic over time, and iron absorption becomes a secondary casualty.